14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

Trading levels for CAPR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.48 4.64 %
R2 5.41 3.15 %
R1 5.36 2.23 %
Current price: 5.24
Support S1 5.20 -0.763 %
S2 5.15 -1.69 %
S3 5.07 -3.18 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 6.38 21.76 %
R2 5.89 12.40 %
R1 5.80 10.69 %
Current price 5.24
Support S1 5.05 -3.63%
S2 5.04 -3.82%
S3 4.82 -8.02%

CAPR Predictions History

3 years ago
JS predicted that CAPR for 2020-05-06 is going $6.29 (-7.50%)

3 years ago
JS predicted that CAPR for 2020-05-05 is going $7.00 (2.19%)

3 years ago
JS predicted that CAPR for 2020-05-04 is going $6.25 (-14.27%)

6 years ago
JS predicted that CAPR for 2018-03-22 is going $1.59 (8.16%)

6 years ago
networld predicted that CAPR for 2017-10-09 is going $0.97 (-65.94%)

Rank:

6 years ago
JS predicted that CAPR for 2017-10-02 is going $2.77 (-19.71%)

6 years ago
mitch.bagdigian.10816 predicted that CAPR for 2017-10-02 is going $3.29 (-4.64%)

6 years ago
JS predicted that CAPR for 2017-09-20 is going $1.97 (-2.96%)

6 years ago
Victor..Li.8930 predicted that CAPR for 2017-07-24 is going $1.33 (18.75%)

6 years ago
JS predicted that CAPR for 2017-07-19 is going $1.21 (4.31%)

Click to get the best stock tips daily for free!

About Capricor Therapeutics

Capricor Therapeutics Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Ph... CAPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT